Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR researchers visit Westminster to see science policy making in action
Last week, two of our researchers here at The Institute of Cancer Research, London, spent a week in Westminster as part of the Royal Society MP Pairing Scheme.
Discovering an intriguing gene link to breast and ovarian cancer
Professor Nazneen Rahman's team found gene mutations linked to an increased risk of breast and ovarian cancer, in what may be a new mechanism of cancer development.
.jpg?sfvrsn=ae545a01_2 "Glioblastoma (Dr Chris Jones/the ICR)")
Identifying the genetic driver of childhood glioblastoma
Dr Chris Jones uncovered the genetic causes of a rare but lethal form of childhood brain cancer, improving our understanding of the development of the disease.
Unlocking the hidden potential of cutting-edge cancer drugs
Professor Paul Workman and collaborators uncovered a hidden mechanism revealing how a class of cutting-edge cancer drugs attack tumours.
.jpg?sfvrsn=e2993eb2_2 "melanoma-cells-(dr-chris-bakal-the-icr)")
Stopping cancer in its tracks
Dr Chris Bakal and his team pinpointed a set of genes that allows melanoma cells to change rapidly between two shapes in order to escape from the skin and spread around the body.
Quantifying breast cancer risk after lymphoma treatment
Professor Tony Swerdlow and colleagues reported on the world’s largest cohort study into factors affecting the risk of breast cancer after treatment with radiotherapy for Hodgkin lymphoma.
New cancer protein inhibitor paves way for research into new treatments
Using virtual experiments to uncover missing cancer targets
Dr Bissan Al-Lazikani and her team identified 46 previously overlooked but potentially 'druggable' cancer targets, using a powerful new online knowledgebase developed here at the ICR.
From lab bench to backbench
Two ICR scientists will be swapping lab coats for legislation when they visit MP Paul Burstow for the Royal Society’s ‘Week in Westminster’ pairing scheme.
Finding the faulty gene with a domino effect on cancer risk
Professors Richard Houlston and Gareth Morgan identified a brand new genetic mechanism that raises the risk of cancer via a domino effect on DNA.
ICR's pioneering prostate cancer drug found to be effective before chemotherapy
Professor Johann de Bono and colleagues found that Abiraterone showed impressive benefits in a major clinical trial of men with early-stage prostate cancer.
Prevent proteins folding and you may stop cancer growing
A molecule that helps cancer cells to keep dividing could be a promising target for new treatments